메뉴 건너뛰기




Volumn 251, Issue 6, 2010, Pages 1098-1106

Angiosarcoma: Clinical and molecular insights

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; IMATINIB; INITIATION FACTOR 4E; INITIATION FACTOR 4E BINDING PROTEIN 1; INTERFERON; IRINOTECAN; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE B; TAXANE DERIVATIVE; VASCULOTROPIN A; VASCULOTROPIN C;

EID: 77953026137     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181dbb75a     Document Type: Article
Times cited : (169)

References (45)
  • 1
    • 84875006287 scopus 로고    scopus 로고
    • The National Institute of Health Accessed March 15, 2009
    • The National Institute of Health. Office of rare diseases. Available at: http://nih.gov/. Accessed March 15, 2009.
    • Office of Rare Diseases
  • 2
    • 53749090994 scopus 로고    scopus 로고
    • Targeted therapies in gastrointestinal stromal tumors
    • Antonescu CR. Targeted therapies in gastrointestinal stromal tumors. Semin Diagn Pathol. 2008;25:295-303.
    • (2008) Semin Diagn Pathol , vol.25 , pp. 295-303
    • Antonescu, C.R.1
  • 3
    • 0030004962 scopus 로고    scopus 로고
    • Prognostic factors in angiosarcoma: A multivariate analysis of 55 cases
    • Naka N, Ohsawa M, Tomita Y, et al. Prognostic factors in angiosarcoma: a multivariate analysis of 55 cases. J Surg Oncol. 1996;61:170-176.
    • (1996) J Surg Oncol , vol.61 , pp. 170-176
    • Naka, N.1    Ohsawa, M.2    Tomita, Y.3
  • 4
    • 33749545556 scopus 로고    scopus 로고
    • A 14-year retrospective review of angiosarcoma: Clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy
    • Fury MG, Antonescu CR, Van Zee KJ, et al. A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy. Cancer J. 2005;11:241-247.
    • (2005) Cancer J , vol.11 , pp. 241-247
    • Fury, M.G.1    Antonescu, C.R.2    Van Zee, K.J.3
  • 5
    • 37349120536 scopus 로고    scopus 로고
    • Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site: A retrospective study of 161 cases
    • Fayette J, Martin E, Piperno-Neumann S, et al. Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site: a retrospective study of 161 cases. Ann Oncol. 2007;18:2030-2036.
    • (2007) Ann Oncol , vol.18 , pp. 2030-2036
    • Fayette, J.1    Martin, E.2    Piperno-Neumann, S.3
  • 6
    • 0022589265 scopus 로고
    • The rapid onset of cutaneous angiosarcoma after radiotherapy for breast carcinoma
    • Otis CN, Peschel R, McKhann C, et al. The rapid onset of cutaneous angiosarcoma after radiotherapy for breast carcinoma. Cancer. 1986;57: 2130-2134.
    • (1986) Cancer , vol.57 , pp. 2130-2134
    • Otis, C.N.1    Peschel, R.2    McKhann, C.3
  • 7
    • 0023192537 scopus 로고
    • Angiosarcoma of the breast following segmental mastectomy complicated by lymphedema
    • Benda JA, Al-Jurf AS, Benson AB III. Angiosarcoma of the breast following segmental mastectomy complicated by lymphedema. Am J Clin Pathol. 1987;87:651-655.
    • (1987) Am J Clin Pathol , vol.87 , pp. 651-655
    • Benda, J.A.1    Al-Jurf, A.S.2    Benson, A.B.3
  • 8
    • 0034534391 scopus 로고    scopus 로고
    • Confirmed angiosarcoma: Prognostic factors and outcome in 50 prospectively followed patients
    • Espat NJ, Lewis JJ, Woodruff JM, et al. Confirmed angiosarcoma: prognostic factors and outcome in 50 prospectively followed patients. Sarcoma. 2000; 4:173-177.
    • (2000) Sarcoma , vol.4 , pp. 173-177
    • Espat, N.J.1    Lewis, J.J.2    Woodruff, J.M.3
  • 9
    • 33750604292 scopus 로고    scopus 로고
    • Protocol for the examination of specimens from patients with soft tissue tumors of intermediate malignant potential, malignant soft tissue tumors, and benign/locally aggressive and malignant bone tumors
    • Rubin BP, Fletcher CD, Inwards C, et al. Protocol for the examination of specimens from patients with soft tissue tumors of intermediate malignant potential, malignant soft tissue tumors, and benign/locally aggressive and malignant bone tumors. Arch Pathol Lab Med. 2006;130:1616-1629.
    • (2006) Arch Pathol Lab Med , vol.130 , pp. 1616-1629
    • Rubin, B.P.1    Fletcher, C.D.2    Inwards, C.3
  • 10
    • 0142189433 scopus 로고    scopus 로고
    • Flecther CD, Unni KK, Mertens F, eds. World health Organization. Classification of Tumors Lyon, France: IARC Press
    • Flecther CD, Unni KK, Mertens F, eds. World health Organization. Classification of Tumors. Pathology and Genetics of Tumors of Soft Tissue and Bone. Lyon, France: IARC Press; 2002.
    • (2002) Pathology and Genetics of Tumors of Soft Tissue and Bone
  • 11
    • 37549041353 scopus 로고    scopus 로고
    • Sporadic cutaneous angio-sarcomas: A proposal for risk stratification based on 69 cases
    • Deyrup AT, McKenney JK, Tighiouart M, et al. Sporadic cutaneous angio-sarcomas: a proposal for risk stratification based on 69 cases. Am J Surg Pathol. 2008;32:72-77.
    • (2008) Am J Surg Pathol , vol.32 , pp. 72-77
    • Deyrup, A.T.1    McKenney, J.K.2    Tighiouart, M.3
  • 12
    • 52649117042 scopus 로고    scopus 로고
    • Midkine enhances soft-tissue sarcoma growth: A possible novel therapeutic target
    • Jin Z, Lahat G, Korchin B, et al. Midkine enhances soft-tissue sarcoma growth: a possible novel therapeutic target. Clin Cancer Res. 2008;14:5033-5042.
    • (2008) Clin Cancer Res , vol.14 , pp. 5033-5042
    • Jin, Z.1    Lahat, G.2    Korchin, B.3
  • 13
    • 65249117712 scopus 로고    scopus 로고
    • Increased vascular endothelial growth factor-C expression is insufficient to induce lymphatic metastasis in human soft-tissue sarcomas
    • Lahat G, Lazar A, Wang X, et al. Increased vascular endothelial growth factor-C expression is insufficient to induce lymphatic metastasis in human soft-tissue sarcomas. Clin Cancer Res. 2009;15:2637-2646.
    • (2009) Clin Cancer Res , vol.15 , pp. 2637-2646
    • Lahat, G.1    Lazar, A.2    Wang, X.3
  • 14
    • 66849131261 scopus 로고    scopus 로고
    • Dual targeting of AKT and mammalian target of rapamycin: A potential therapeutic approach for malignant peripheral nerve sheath tumor.
    • press
    • Zou CY, Smith KD, Zhu QS, et al. Dual targeting of AKT and mammalian target of rapamycin: a potential therapeutic approach for malignant peripheral nerve sheath tumor. Mol Cancer Ther. In press.
    • Mol Cancer Ther
    • Zou, C.Y.1    Smith, K.D.2    Zhu, Q.S.3
  • 15
    • 51649102507 scopus 로고    scopus 로고
    • New perspectives for staging and prognosis in soft tissue sarcoma
    • Lahat G, Tuvin D, Wei C, et al. New perspectives for staging and prognosis in soft tissue sarcoma. Ann Surg Oncol. 2008;15:2739-2748.
    • (2008) Ann Surg Oncol , vol.15 , pp. 2739-2748
    • Lahat, G.1    Tuvin, D.2    Wei, C.3
  • 16
    • 29144524677 scopus 로고    scopus 로고
    • Angiosarcoma of the breast
    • Vorburger SA, Xing Y, Hunt KK, et al. Angiosarcoma of the breast. Cancer. 2005;104:2682-2688.
    • (2005) Cancer , vol.104 , pp. 2682-2688
    • Vorburger, S.A.1    Xing, Y.2    Hunt, K.K.3
  • 17
    • 34249865898 scopus 로고    scopus 로고
    • Treatment and outcome of 82 patients with angiosarcoma
    • Abraham JA, Hornicek FJ, Kaufman AM, et al. Treatment and outcome of 82 patients with angiosarcoma. Ann Surg Oncol. 2007;14:1953-1967.
    • (2007) Ann Surg Oncol , vol.14 , pp. 1953-1967
    • Abraham, J.A.1    Hornicek, F.J.2    Kaufman, A.M.3
  • 18
    • 42949119654 scopus 로고    scopus 로고
    • Prognostic factors for adult sarcomas of head and neck
    • Penel N, Mallet Y, Robin YM, et al. Prognostic factors for adult sarcomas of head and neck. Int J Oral Maxillofac Surg. 2008;37:428-432.
    • (2008) Int J Oral Maxillofac Surg , vol.37 , pp. 428-432
    • Penel, N.1    Mallet, Y.2    Robin, Y.M.3
  • 19
    • 55949086834 scopus 로고    scopus 로고
    • Phase II trial of weekly paclitaxel for unresectable angiosarcoma: The ANGIOTAX study
    • Penel N, Bui BN, Bay JO, et al. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX study. J Clin Oncol. 2008;26: 5269-5274.
    • (2008) J Clin Oncol , vol.26 , pp. 5269-5274
    • Penel, N.1    Bui, B.N.2    Bay, J.O.3
  • 20
    • 0030700784 scopus 로고    scopus 로고
    • A phase i study of ambulatory continuous infusion paclitaxel
    • Skubitz KM. A phase I study of ambulatory continuous infusion paclitaxel. Anticancer Drugs. 1997;8:823-828.
    • (1997) Anticancer Drugs , vol.8 , pp. 823-828
    • Skubitz, K.M.1
  • 21
    • 0033571557 scopus 로고    scopus 로고
    • Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face
    • Fata F, O'Reilly E, Ilson D, et al. Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer. 1999;86:2034-2037.
    • (1999) Cancer , vol.86 , pp. 2034-2037
    • Fata, F.1    O'Reilly, E.2    Ilson, D.3
  • 22
    • 0031709550 scopus 로고    scopus 로고
    • Phase II trial of paclitaxel in patients with soft-tissue sarcoma
    • Casper ES, Waltzman RJ, Schwartz GK, et al. Phase II trial of paclitaxel in patients with soft-tissue sarcoma. Cancer Invest. 1998;16:442-446.
    • (1998) Cancer Invest , vol.16 , pp. 442-446
    • Casper, E.S.1    Waltzman, R.J.2    Schwartz, G.K.3
  • 23
    • 38849182248 scopus 로고    scopus 로고
    • Improved outcome with multimodality therapy in primary cardiac angiosarcoma
    • Pigott C, Welker M, Khosla P, et al. Improved outcome with multimodality therapy in primary cardiac angiosarcoma. Nat Clin Pract Oncol. 2008;5:112-115.
    • (2008) Nat Clin Pract Oncol , vol.5 , pp. 112-115
    • Pigott, C.1    Welker, M.2    Khosla, P.3
  • 24
  • 25
    • 2542484761 scopus 로고    scopus 로고
    • Cutaneous angiosarcoma following breast-conserving surgery and radiation: An analysis of 27 cases
    • Billings SD, McKenney JK, Folpe AL, et al. Cutaneous angiosarcoma following breast-conserving surgery and radiation: an analysis of 27 cases. Am J Surg Pathol. 2004;28:781-788.
    • (2004) Am J Surg Pathol , vol.28 , pp. 781-788
    • Billings, S.D.1    McKenney, J.K.2    Folpe, A.L.3
  • 26
    • 33645057934 scopus 로고    scopus 로고
    • Grading of soft tissue sarcomas: The challenge of providing precise information in an imprecise world
    • Deyrup AT, Weiss SW. Grading of soft tissue sarcomas: the challenge of providing precise information in an imprecise world. Histopathology. 2006; 48:42-50.
    • (2006) Histopathology , vol.48 , pp. 42-50
    • Deyrup, A.T.1    Weiss, S.W.2
  • 27
    • 58749109288 scopus 로고    scopus 로고
    • Primary angiosarcoma of the breast: Clinicopathologic analysis of 49 cases, suggesting that grade is not prognostic
    • Nascimento AF, Raut CP, Fletcher CD. Primary angiosarcoma of the breast: clinicopathologic analysis of 49 cases, suggesting that grade is not prognostic. Am J Surg Pathol. 2008;32:1896-1904.
    • (2008) Am J Surg Pathol , vol.32 , pp. 1896-1904
    • Nascimento, A.F.1    Raut, C.P.2    Fletcher, C.D.3
  • 28
    • 0029686511 scopus 로고    scopus 로고
    • Vascular tumors: An update with emphasis on the diagnosis of angiosarcoma and borderline vascular neoplasms
    • Fletcher CD. Vascular tumors: an update with emphasis on the diagnosis of angiosarcoma and borderline vascular neoplasms. Monogr Pathol. 1996;38: 181-206.
    • (1996) Monogr Pathol , vol.38 , pp. 181-206
    • Fletcher, C.D.1
  • 29
    • 57149117848 scopus 로고    scopus 로고
    • A decade of tissue microarrays: Progress in the discovery and validation of cancer biomarkers
    • Camp RL, Neumeister V, Rimm DL. A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers. J Clin Oncol. 2008;26: 5630-5637.
    • (2008) J Clin Oncol , vol.26 , pp. 5630-5637
    • Camp, R.L.1    Neumeister, V.2    Rimm, D.L.3
  • 30
    • 33845949059 scopus 로고    scopus 로고
    • Secondary breast angiosarcoma: Lethal response to anti-angiogenic therapy with paclitaxel chemotherapy. A case report
    • Tomasello L, Gardin G, Boccardo F. Secondary breast angiosarcoma: lethal response to anti-angiogenic therapy with paclitaxel chemotherapy. A case report. Anticancer Res. 2006;26:4775-4777.
    • (2006) Anticancer Res , vol.26 , pp. 4775-4777
    • Tomasello, L.1    Gardin, G.2    Boccardo, F.3
  • 31
    • 0029564159 scopus 로고
    • Expression of vascular endothe-lial growth factor and its receptor mRNA in angiosarcoma
    • Hashimoto M, Ohsawa M, Ohnishi A, et al. Expression of vascular endothe-lial growth factor and its receptor mRNA in angiosarcoma. Lab Invest. 1995;73:859-863.
    • (1995) Lab Invest , vol.73 , pp. 859-863
    • Hashimoto, M.1    Ohsawa, M.2    Ohnishi, A.3
  • 32
    • 39149092712 scopus 로고    scopus 로고
    • Preoperative radiotherapy and bevacizumab for angiosarcoma of the head and neck: Two case studies
    • Koontz BF, Miles EF, Rubio MA, et al. Preoperative radiotherapy and bevacizumab for angiosarcoma of the head and neck: two case studies. Head Neck. 2008;30:262-266.
    • (2008) Head Neck , vol.30 , pp. 262-266
    • Koontz, B.F.1    Miles, E.F.2    Rubio, M.A.3
  • 33
    • 43249092388 scopus 로고    scopus 로고
    • Phosphorylated epidermal growth factor receptor on tumor-associated endothelial cells is a primary target for therapy with tyrosine kinase inhibitors
    • Kuwai T, Nakamura T, Sasaki T, et al. Phosphorylated epidermal growth factor receptor on tumor-associated endothelial cells is a primary target for therapy with tyrosine kinase inhibitors. Neoplasia. 2008;10:489-500.
    • (2008) Neoplasia , vol.10 , pp. 489-500
    • Kuwai, T.1    Nakamura, T.2    Sasaki, T.3
  • 34
    • 0034083341 scopus 로고    scopus 로고
    • KIT expression in angiosarcomas and fetal endothelial cells: Lack of mutations of exon 11 and exon 17 of C-kit
    • Miettinen M, Sarlomo-Rikala M, Lasota J. KIT expression in angiosarcomas and fetal endothelial cells: lack of mutations of exon 11 and exon 17 of C-kit. Mod Pathol. 2000;13:536-541.
    • (2000) Mod Pathol , vol.13 , pp. 536-541
    • Miettinen, M.1    Sarlomo-Rikala, M.2    Lasota, J.3
  • 35
    • 0028116487 scopus 로고
    • Expression of c-kit and kit ligand proteins in normal human tissues
    • Lammie A, Drobnjak M, Gerald W, et al. Expression of c-kit and kit ligand proteins in normal human tissues. J Histochem Cytochem. 1994;42:1417-1425.
    • (1994) J Histochem Cytochem , vol.42 , pp. 1417-1425
    • Lammie, A.1    Drobnjak, M.2    Gerald, W.3
  • 36
    • 62549158253 scopus 로고    scopus 로고
    • Dramatic and durable efficacy of imatinib in an advanced angiosarcoma without detectable KIT and PDG-FRA mutations
    • Kiesel H, Muller AM, Schmitt-Graeff A, et al. Dramatic and durable efficacy of imatinib in an advanced angiosarcoma without detectable KIT and PDG-FRA mutations. Cancer Biol Ther. 2009;8:319-321.
    • (2009) Cancer Biol Ther , vol.8 , pp. 319-321
    • Kiesel, H.1    Muller, A.M.2    Schmitt-Graeff, A.3
  • 37
    • 0000440912 scopus 로고    scopus 로고
    • Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase
    • Chang HW, Aoki M, Fruman D, et al. Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase. Science. 1997;276:1848-1850.
    • (1997) Science , vol.276 , pp. 1848-1850
    • Chang, H.W.1    Aoki, M.2    Fruman, D.3
  • 38
    • 0032443803 scopus 로고    scopus 로고
    • The akt kinase: Molecular determinants of oncogenicity
    • Aoki M, Batista O, Bellacosa A, et al. The akt kinase: molecular determinants of oncogenicity. Proc Natl Acad Sci USA. 1998;95:14950-14955.
    • (1998) Proc Natl Acad Sci USA , vol.95 , pp. 14950-14955
    • Aoki, M.1    Batista, O.2    Bellacosa, A.3
  • 39
    • 34247373748 scopus 로고    scopus 로고
    • AKT1 overexpression in endo-thelial cells leads to the development of cutaneous vascular malformations in vivo
    • Perry B, Banyard J, McLaughlin ER, et al. AKT1 overexpression in endo-thelial cells leads to the development of cutaneous vascular malformations in vivo. Arch Dermatol. 2007;143:504-506.
    • (2007) Arch Dermatol , vol.143 , pp. 504-506
    • Perry, B.1    Banyard, J.2    McLaughlin, E.R.3
  • 40
    • 33746800144 scopus 로고    scopus 로고
    • Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin
    • Phung TL, Ziv K, Dabydeen D, et al. Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin. Cancer Cell. 2006;10: 159-170.
    • (2006) Cancer Cell , vol.10 , pp. 159-170
    • Phung, T.L.1    Ziv, K.2    Dabydeen, D.3
  • 41
    • 24644509362 scopus 로고    scopus 로고
    • Mutations of phosphatase and tensin homolog deleted from chromosome 10 in canine hemangiosarcoma
    • Dickerson EB, Thomas R, Fosmire SP, et al. Mutations of phosphatase and tensin homolog deleted from chromosome 10 in canine hemangiosarcoma. Vet Pathol. 2005;42:618-632.
    • (2005) Vet Pathol , vol.42 , pp. 618-632
    • Dickerson, E.B.1    Thomas, R.2    Fosmire, S.P.3
  • 42
    • 33846295218 scopus 로고    scopus 로고
    • FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis
    • Paik JH, Kollipara R, Chu G, et al. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell. 2007;128: 309-323.
    • (2007) Cell , vol.128 , pp. 309-323
    • Paik, J.H.1    Kollipara, R.2    Chu, G.3
  • 43
    • 66849131261 scopus 로고    scopus 로고
    • Dual targeting of AKT and mammalian target of Rapamycin: A potential therapeutic approach for malignant peripheral nerve sheath tumor
    • press
    • Zou C, Smith KD, Zhu QS, et al. Dual targeting of AKT and mammalian target of Rapamycin: a potential therapeutic approach for malignant peripheral nerve sheath tumor. Mol Cancer Ther. In press.
    • Mol Cancer Ther
    • Zou, C.1    Smith, K.D.2    Zhu, Q.S.3
  • 44
    • 0037020044 scopus 로고    scopus 로고
    • Identification of TOR signaling complexes: More TORC for the cell growth engine
    • Abraham RT. Identification of TOR signaling complexes: more TORC for the cell growth engine. Cell. 2002;4:9-12.
    • (2002) Cell , vol.4 , pp. 9-12
    • Abraham, R.T.1
  • 45
    • 23144467910 scopus 로고    scopus 로고
    • An expanding role for mTOR in cancer
    • Guertin DA, Sabatini DM. An expanding role for mTOR in cancer. Trends Mol Med. 2005;11:353-361.
    • (2005) Trends Mol Med , vol.11 , pp. 353-361
    • Guertin, D.A.1    Sabatini, D.M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.